Get the Stockscreener App
4.69
4.87%
-0.24
Pre-market:
4.59
-0.10
-2.13%
Nuvation Bio Inc stock is traded at $4.69, with a volume of 5.76M.
It is down -4.87% in the last 24 hours and up +27.45% over the past month.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
See More
Previous Close:
$4.93
Open:
$4.85
24h Volume:
5.76M
Relative Volume:
0.77
Market Cap:
$1.61B
Revenue:
-
Net Income/Loss:
$-75.80M
P/E Ratio:
-13.40
EPS:
-0.35
Net Cash Flow:
$-68.07M
1W Performance:
-6.57%
1M Performance:
+27.45%
6M Performance:
+114.16%
1Y Performance:
+58.98%
1-Day Range:
$4.66
$4.945
1-Week Range:
$4.45
$5.15
52-Week Range:
$1.54
$5.55
Nuvation Bio Inc Stock (NUVB) Company Profile
Name
Nuvation Bio Inc
Sector
Industry
Phone
(415) 754-3517
Address
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Compare NUVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
4.69 | 1.69B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.98B | 69.59M | 525.67M | 0.5197 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Initiated | Jefferies | Buy |
| Apr-23-25 | Initiated | Citizens JMP | Mkt Outperform |
| Mar-27-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-26-24 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-06-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-02-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Aug-02-22 | Downgrade | BTIG Research | Buy → Neutral |
| May-04-22 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Apr-06-21 | Initiated | RBC Capital Mkts | Outperform |
| Mar-08-21 | Initiated | BMO Capital Markets | Outperform |
| Mar-08-21 | Initiated | BTIG Research | Buy |
| Mar-08-21 | Initiated | Cowen | Outperform |
| Mar-08-21 | Initiated | Jefferies | Buy |
| Mar-08-21 | Initiated | Wedbush | Outperform |
View All
Nuvation Bio Inc Stock (NUVB) Latest News
How Nuvation Bio Inc. stock reacts to inflationary pressuresRisk Management & Weekly Setup with ROI Potential - newser.com
Will Nuvation Bio Inc. Warrants stock benefit from mergersJuly 2025 Recap & Long-Term Safe Investment Ideas - newser.com
Is Nuvation Bio Inc. stock recession proofJuly 2025 Analyst Calls & High Accuracy Trade Alerts - newser.com
Will Nuvation Bio Inc. Class stock profit from AI boomPortfolio Update Summary & Short-Term Trading Alerts - newser.com
Can you recover from losses in Nuvation Bio Inc.2025 Technical Overview & Technical Pattern Alert System - newser.com
Is Nuvation Bio Inc. Warrants stock a defensive play amid uncertaintyTrade Signal Summary & Daily Technical Forecast Reports - newser.com
Can Nuvation Bio Inc. stock maintain operating margins2025 Market Sentiment & AI Optimized Trade Strategies - newser.com
What candlestick patterns are forming on Nuvation Bio Inc.Weekly Trend Summary & AI Based Trade Execution Alerts - newser.com
Is Nuvation Bio Inc. stock overvalued by current metrics2025 Price Targets & Technical Pattern Based Buy Signals - newser.com
JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans - MSN
Can Nuvation Bio Inc. stock deliver surprise earnings beatJuly 2025 Outlook & Long Hold Capital Preservation Plans - newser.com
November 2025's Top Penny Stocks To Watch - simplywall.st
Published on: 2025-11-11 23:40:37 - newser.com
Sector ETF performance correlation with Nuvation Bio Inc.July 2025 Patterns & Technical Entry and Exit Alerts - newser.com
Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock - AOL.com
Will Nuvation Bio Inc. price bounce be sustainableJuly 2025 Volume & High Accuracy Swing Entry Alerts - newser.com
How Nuvation Bio Inc. Warrants stock compares with tech leadersMarket Activity Report & Real-Time Volume Spike Alerts - newser.com
What data driven models say about Nuvation Bio Inc.’s futureQuarterly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Nuvation Bio Inc Stock (NUVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):